Healthcare

Moolec Science Receives Nasdaq Delisting Determination After Voluntary Liquidation Approval

Moolec Science SA in Voluntary Liquidation has received a Nasdaq determination to delist its ordinary shares after shareholders approved the company’s voluntary winding-up.

Published:
Reading Time
2 min

Moolec Science SA in Voluntary Liquidation (Nasdaq:MLEC) has received a Staff Delisting Determination from The Nasdaq Stock Market LLC after shareholders approved the company’s voluntary winding-up and the appointment of Joint Voluntary Liquidators.

#Nasdaq determination follows shareholder vote

The company said it received Nasdaq’s letter on October 27, 2026. The determination followed an Extraordinary General Meeting held on October 20, 2026, where shareholders approved resolutions relating to the voluntary liquidation.

The resolutions received 98.4% of the votes cast in favor. Cassandra Ronaldson and Amiel Gottlieb of Interpath were appointed as Joint Voluntary Liquidators.

#Basis for the proposed delisting

Nasdaq made its determination under Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1. The company said the decision was linked to its voluntary winding-up and related public interest considerations.

Those considerations included the residual equity interests of existing shareholders and Moolec Science’s ability to continue meeting Nasdaq’s requirements for maintaining a listing.

#Trading suspension scheduled for November 3

According to the notification described by the company, trading in Moolec Science’s ordinary shares is scheduled to be suspended at the opening of business on November 3, 2026.

Nasdaq is then expected to file a Form 25-NSE with the U.S. Securities and Exchange Commission to carry out the delisting of the ordinary shares from Nasdaq. The announcement concerns a delisting determination and the related process; it does not state that the delisting has already been completed.

#Company remains in voluntary liquidation

Moolec Science SA in Voluntary Liquidation is incorporated under the laws of the Cayman Islands and is currently undergoing voluntary liquidation following the shareholder resolutions approved on October 20, 2026.

#Key Takeaways

  • Moolec Science received Nasdaq’s Staff Delisting Determination letter on October 27, 2026.
  • Shareholders approved the voluntary winding-up and appointment of Joint Voluntary Liquidators on October 20, 2026.
  • The resolutions received 98.4% of the votes cast in favor.
  • Trading in the company’s ordinary shares is scheduled to be suspended at the opening of business on November 3, 2026.
  • Nasdaq is expected to file Form 25-NSE with the U.S. Securities and Exchange Commission to effect the delisting.

Original source: Read original article

Frequently Asked Questions